Regulation of Butyrate-Induced Resistance through AMPK Signaling Pathway in Human Colon Cancer Cells

Butyrates inhibit cell growth in colon cancer cells by inhibiting histone deacetylases. However, chronic exposure to butyrates induces butyrate resistance in colon cancer cells. The mechanism underlying the acquisition of resistance is not yet fully understood. Here, butyrate-resistant (BR) colon ca...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hee Young Yoo, So Yeon Park, Sun-Young Chang, So Hee Kim
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
ACC
Akt
Acceso en línea:https://doaj.org/article/ad6809eb5c554f9e925b58b9b9ce86be
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ad6809eb5c554f9e925b58b9b9ce86be
record_format dspace
spelling oai:doaj.org-article:ad6809eb5c554f9e925b58b9b9ce86be2021-11-25T16:49:32ZRegulation of Butyrate-Induced Resistance through AMPK Signaling Pathway in Human Colon Cancer Cells10.3390/biomedicines91116042227-9059https://doaj.org/article/ad6809eb5c554f9e925b58b9b9ce86be2021-11-01T00:00:00Zhttps://www.mdpi.com/2227-9059/9/11/1604https://doaj.org/toc/2227-9059Butyrates inhibit cell growth in colon cancer cells by inhibiting histone deacetylases. However, chronic exposure to butyrates induces butyrate resistance in colon cancer cells. The mechanism underlying the acquisition of resistance is not yet fully understood. Here, butyrate-resistant (BR) colon cancer cells were developed in HCT116, HT29, and SW480 human colon cancer cells and were confirmed by the increase in the inhibitory concentrations of cell growth by 50% (IC<sub>50</sub>) compared to their respective parental (PT) cells. Chronic exposure to butyrate induced autophagy via higher expression of Beclin-1 and LC3B-II. The AMP-activated protein kinase (AMPK) was downregulated along with the activation of Akt and mammalian target of rapamycin (mTOR) and decrease in acetyl-CoA carboxylase (ACC) in BR colon cancer cells compared to those in their respective PT cells. Activation of AMPK by AICAR treatment in BR colon cancer cells suppressed cell proliferation by inhibiting Akt and mTOR and activating ACC. Taken together, chronic exposure to butyrate increased butyrate resistance in human colon cancer by inducing protective autophagy through the downregulation of AMPK/ACC and activation of Akt/mTOR signaling. Activation of AMPK restored sensitivity to butyrate by the inhibition of Akt/mTOR, suggesting that AMPK could be a therapeutic target for BR colon cancers.Hee Young YooSo Yeon ParkSun-Young ChangSo Hee KimMDPI AGarticlebutyrate resistancecolon cancerAMPKautophagyACCAktBiology (General)QH301-705.5ENBiomedicines, Vol 9, Iss 1604, p 1604 (2021)
institution DOAJ
collection DOAJ
language EN
topic butyrate resistance
colon cancer
AMPK
autophagy
ACC
Akt
Biology (General)
QH301-705.5
spellingShingle butyrate resistance
colon cancer
AMPK
autophagy
ACC
Akt
Biology (General)
QH301-705.5
Hee Young Yoo
So Yeon Park
Sun-Young Chang
So Hee Kim
Regulation of Butyrate-Induced Resistance through AMPK Signaling Pathway in Human Colon Cancer Cells
description Butyrates inhibit cell growth in colon cancer cells by inhibiting histone deacetylases. However, chronic exposure to butyrates induces butyrate resistance in colon cancer cells. The mechanism underlying the acquisition of resistance is not yet fully understood. Here, butyrate-resistant (BR) colon cancer cells were developed in HCT116, HT29, and SW480 human colon cancer cells and were confirmed by the increase in the inhibitory concentrations of cell growth by 50% (IC<sub>50</sub>) compared to their respective parental (PT) cells. Chronic exposure to butyrate induced autophagy via higher expression of Beclin-1 and LC3B-II. The AMP-activated protein kinase (AMPK) was downregulated along with the activation of Akt and mammalian target of rapamycin (mTOR) and decrease in acetyl-CoA carboxylase (ACC) in BR colon cancer cells compared to those in their respective PT cells. Activation of AMPK by AICAR treatment in BR colon cancer cells suppressed cell proliferation by inhibiting Akt and mTOR and activating ACC. Taken together, chronic exposure to butyrate increased butyrate resistance in human colon cancer by inducing protective autophagy through the downregulation of AMPK/ACC and activation of Akt/mTOR signaling. Activation of AMPK restored sensitivity to butyrate by the inhibition of Akt/mTOR, suggesting that AMPK could be a therapeutic target for BR colon cancers.
format article
author Hee Young Yoo
So Yeon Park
Sun-Young Chang
So Hee Kim
author_facet Hee Young Yoo
So Yeon Park
Sun-Young Chang
So Hee Kim
author_sort Hee Young Yoo
title Regulation of Butyrate-Induced Resistance through AMPK Signaling Pathway in Human Colon Cancer Cells
title_short Regulation of Butyrate-Induced Resistance through AMPK Signaling Pathway in Human Colon Cancer Cells
title_full Regulation of Butyrate-Induced Resistance through AMPK Signaling Pathway in Human Colon Cancer Cells
title_fullStr Regulation of Butyrate-Induced Resistance through AMPK Signaling Pathway in Human Colon Cancer Cells
title_full_unstemmed Regulation of Butyrate-Induced Resistance through AMPK Signaling Pathway in Human Colon Cancer Cells
title_sort regulation of butyrate-induced resistance through ampk signaling pathway in human colon cancer cells
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/ad6809eb5c554f9e925b58b9b9ce86be
work_keys_str_mv AT heeyoungyoo regulationofbutyrateinducedresistancethroughampksignalingpathwayinhumancoloncancercells
AT soyeonpark regulationofbutyrateinducedresistancethroughampksignalingpathwayinhumancoloncancercells
AT sunyoungchang regulationofbutyrateinducedresistancethroughampksignalingpathwayinhumancoloncancercells
AT soheekim regulationofbutyrateinducedresistancethroughampksignalingpathwayinhumancoloncancercells
_version_ 1718412915614154752